Questions for the Harvard case “Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug” For March 20‚ write responses to the following questions for the Metabical case. 1) How is Metabical different from the existing weight-loss options? How is it better or worse than the other options? Metabical is the first prescription drug approved specifically for overweight individuals (BMI between 25 and 30)‚ those individuals who have weight-loss goals of approximately
Premium Obesity Weight loss Nutrition
Mai Nguyen New Product Planning Professor Patton 3/5/14 Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug Case 1. How does Metabical compare to current weight-loss options? There are only several other weight-loss options in the market competing with Metabical. The first is prescription drugs. These are prescribed for use only by obese and severely obese individuals. This meant that only individuals with BMI of over 30 who were prescribed weight-loss drugs
Premium Obesity Medical prescription Drugs
Metabical (Case study) Case Facts • Metabical is a prescription drug produced by Cambridge Sciences Pharmaceuticals (CSP) for weight loss. • It was the first and only prescription drug to obtain FDA approval for weight loss (overweight category) drug. • The company had conducted an elaborate market research program for identifying the target segment and positioning the product. • Competitors: FDA approved OTC drug Alli. • Marketing strategy: – DTC advertising- celebrity endorser‚ TV‚ radio‚
Premium Obesity Food and Drug Administration Marketing
Communication Activities 4.4 Promotional Strategies 4.4.1 Advertising Strategies 4.4.2 Promotion and Public Relations 4.4.3 Sales Force 4.4.4 Comprehensive Support Program 4.5 Product Strategies 4.6 Distribution Strategies 4.7 Pricing Strategies 4.7.1 Potential Customer 4.7.2 Sales Forecast 4.7.3 Return on Investment (ROI) Conclusion 4.0 5.0 1 1.0 INTRODUCTION Cambridge Science Pharmaceuticals (CSP) was an International health care company with a focus on developing‚ manufacturing‚ and marketing
Premium Marketing Obesity Weight loss
1. How does Metabical compare to current weight-loss options? Answer: Metabical is revolutionary product and forecasted to be the first FDA approved prescriptive drug for overweight individuals with weight-loss goals. The previous prescriptive drugs have a negative side effects that out weighed its positives. Metabical‚ on the other hand‚ did not display as many negative effects in its trail runs and thus was being strongly endorsed by the medical community. The current weight-loss drugs can be
Premium Obesity Weight loss Cancer
272593 BUS 474 A 02/14/2011 Metabical After spending millions of dollars for ten years in research and development‚ Metabical was finally able to receive FDA approval‚ making it the first and only drug to receive FDA approval to meet the needs of customers who have been trying to lose weight. Like with any other new product‚ numerous issues need to be considered before Metabical is actually introduced in the market. Decisions about pricing‚ packaging and demand forecast of the product are key to the
Premium Obesity Pharmacology
1. How does Metabical compare to current weight-loss options? * It was the only prescription drug to achieve the FDA * No side effects * Moderate weight loss for overweight people not the obese like other weightloss drugs * Dual layer controlled realise formulation. First layer appetite suppressant‚ 2nd layer is the fat blocker. Low dose levels of chemicals‚ so doesn’t cause heart or liver diseases. 2. What are the pros and cons of the forecasting methods presented by Printup
Premium Obesity Weight loss
shown in Figure 1 below. Figure 1 The total subscriber base as at June 2013 stood at 671.13 million. Figure 2 below shows the major GSM operator wise number of subscribers as at June 2013. Figure 2 In our project we have attempted to forecast the demand of mobile subscriptions in North India in the Month of December 2013 by use of the following models: Logistics Curve Gompertz Curve Bass Model Logistics Curve: A logistic function or logistic curve is a common sigmoid function‚ given
Premium Logistic function Logistic regression
towards both men and women; however‚ a focus on women may be more worthwhile. In terms of weight-loss‚ women exhibit more of a desire to change their overall body image‚ and showcase a motivation to eat‚ look‚ and feel healthier. (See Exhibit 3 in Case Book) Metabical’s age demographic segmentation would have a stronger response from the middle 25-34‚ 35-44‚ and 45-54-age sector that is moderately overweight (BMI of 25-30). These age brackets more likely have the financial means to purchase such
Premium Obesity Weight loss Medical prescription
B Problem Statement Barbara Printup must determine the packaging for Metabical that will best capture the accurately forecasted demand of the target market. With many substitutes for weight loss in a variety of packages and price points‚ it will be important to create a package that can be priced in a way to both drive sales and continued use of the 12-week drug. Printup must also develop a pricing model to align with the packaging and the price expectations of the target market. Since this is
Premium Price Marketing Price point